AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35593710 — intervention group
Group type: EXPERIMENTAL
Intervention: Burr Hole Craniostomy (BHC)
Number of subjects: 245
Study 35593710 — intervention group
Group type: EXPERIMENTAL
Intervention: Minicraniotomy (MC)
Number of subjects: 245
Study 35593710 — intervention group
Group type: EXPERIMENTAL
Intervention: Twist Drill Craniostomy (TDC)
Number of subjects: 245
Study 33331008 — intervention group
Group type: EXPERIMENTAL
Intervention: EBI-OTM
Number of subjects: 3
Study 33331008 — intervention group
Group type: EXPERIMENTAL
Intervention: EBI-LS
Number of subjects: 3
Study 33331008 — intervention group
Group type: COMPARATOR
Intervention: CI
Number of subjects: 3
Study 32824995 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood maltreatment (physical abuse)
Number of subjects: 21019
Study 32824995 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood maltreatment (emotional abuse)
Number of subjects: 21019
Study 32824995 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood maltreatment (sexual abuse)
Number of subjects: 21019
Study 32824995 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood maltreatment (physical neglect)
Number of subjects: 21019
Study 32824995 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood maltreatment (emotional neglect)
Number of subjects: 21019
Study 32824995 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood maltreatment
Number of subjects: 21019
Study 36437383 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg rosuvastatin plus 10 mg ezetimibe
Number of subjects: 12
Study 36437383 — intervention group
Group type: COMPARATOR
Intervention: 10 mg rosuvastatin alone
Number of subjects: 12
Study 36437383 — intervention group
Group type: COMPARATOR
Intervention: 10 mg ezetimibe alone
Number of subjects: 12
Study 36437383 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ezetimibe plus 10 mg rosuvastatin
Number of subjects: 12
Study 34101900 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcifediol 0.266 mg/month for 12 months
Number of subjects: 303
Study 34101900 — intervention group
Group type: COMPARATOR
Intervention: Cholecalciferol 25,000 IU/month for 12 months
Number of subjects: 303
Study 34101900 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcifediol 0.266 mg/month for 4 months followed by placebo for 8 months
Number of subjects: 303
Study 32912942 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Peanut Oral ImmunoTherapy (PPOIT)
Number of subjects: 200
Study 32912942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 32912942 — intervention group
Group type: COMPARATOR
Intervention: Peanut OIT alone
Number of subjects: 200
Study 36268671 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 130
Study 36268671 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 130
Study 35046656 — intervention group
Group type: EXPERIMENTAL
Intervention: Jingxin Zhidong Formula (JXZDF) 17.6 g/day
Number of subjects: 120
Study 35046656 — intervention group
Group type: COMPARATOR
Intervention: aripiprazole 10 mg/day
Number of subjects: 120
Study 33203026 — intervention group
Group type: EXPERIMENTAL
Intervention: Regularized Randomized Neural Network (RRNN)
Number of subjects: 0
Study 33203026 — intervention group
Group type: EXPERIMENTAL
Intervention: Kernel Ridge Regression Neural Network (KRR)
Number of subjects: 0
Study 33203026 — intervention group
Group type: COMPARATOR
Intervention: Conventional support vector machine
Number of subjects: 0
Study 33203026 — intervention group
Group type: COMPARATOR
Intervention: Extreme learning based solutions
Number of subjects: 0
Study 35977701 — intervention group
Group type: EXPERIMENTAL
Intervention: Water birth
Number of subjects: 120
Study 35977701 — intervention group
Group type: COMPARATOR
Intervention: Conventional birth
Number of subjects: 120
Study 33475230 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy threshold of prostate-specific antigen > 3.0
Number of subjects: 144
Study 33475230 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy threshold of > 15% from the European Randomized Study of Screening for Prostate Cancer calculator
Number of subjects: 144
Study 33475230 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy threshold of > 5% risk
Number of subjects: 144
Study 32869069 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced oropharyngeal suctioning every 4 hours
Number of subjects: 513
Study 32869069 — intervention group
Group type: COMPARATOR
Intervention: Sham suctioning
Number of subjects: 513
Study 32869069 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients intubated at another hospital and transferred
Number of subjects: 513
Study 32869069 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients intubated in the field
Number of subjects: 513
Study 36286922 — intervention group
Group type: EXPERIMENTAL
Intervention: Raphamin
Number of subjects: 240
Study 36286922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 34887283 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored Diabetes Self-Management Education (DSME) program
Number of subjects: 4000000
Study 34887283 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 4000000
Study 32359361 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy intervention (seven-day programme including music sessions)
Number of subjects: 81
Study 32359361 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic education (seven sessions of spoken word)
Number of subjects: 81
Study 32359361 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy intervention
Number of subjects: 81
Study 35614277 — intervention group
Group type: EXPERIMENTAL
Intervention: app‐assisted interactive power toothbrush (PTB‐A)
Number of subjects: 90
Study 35614277 — intervention group
Group type: EXPERIMENTAL
Intervention: non-app‐assisted interactive power toothbrush (PTB‐NA)
Number of subjects: 90
Study 35614277 — intervention group
Group type: COMPARATOR
Intervention: manual toothbrush (MTB)
Number of subjects: 90
Study 35614277 — intervention group
Group type: EXPERIMENTAL
Intervention: both PTBs (PTB‐A and PTB‐NA)
Number of subjects: 90
Study 33770392 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafamidis
Number of subjects: 441
Study 33770392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 441
Study 32367867 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg (Group O)
Number of subjects: 109
Study 32367867 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg (Group T)
Number of subjects: 109
Study 32367867 — intervention group
Group type: COMPARATOR
Intervention: Saline 4 ml (Group S)
Number of subjects: 109
Study 34636271 — intervention group
Group type: EXPERIMENTAL
Intervention: Worksheet exercise to enhance reporting behavior
Number of subjects: 503
Study 32040523 — intervention group
Group type: EXPERIMENTAL
Intervention: Family economic empowerment (EE) intervention
Number of subjects: 288
Study 32040523 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 288
Study 32040523 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher number of medications per day
Number of subjects: 288
Study 34166033 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg nicotine
Number of subjects: 0
Study 34166033 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg nicotine
Number of subjects: 0
Study 34166033 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34414154 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy for my Baby intervention
Number of subjects: 68
Study 34414154 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 68
Study 35357762 — intervention group
Group type: EXPERIMENTAL
Intervention: AE + BFR (aerobic exercise with blood flow restriction)
Number of subjects: 22
Study 35357762 — intervention group
Group type: EXPERIMENTAL
Intervention: HIAE (high-intensity aerobic exercise)
Number of subjects: 22
Study 35357762 — intervention group
Group type: COMPARATOR
Intervention: AE (aerobic exercise without BFR)
Number of subjects: 22
Study 35357762 — intervention group
Group type: COMPARATOR
Intervention: CON (non-exercise control condition)
Number of subjects: 22
Study 35357762 — intervention group
Group type: EXPERIMENTAL
Intervention: HIAE
Number of subjects: 22
Study 35357762 — intervention group
Group type: EXPERIMENTAL
Intervention: AE + BFR
Number of subjects: 22
Study 35357762 — intervention group
Group type: COMPARATOR
Intervention: AE
Number of subjects: 22
Study 35357762 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 22
Study 33892046 — intervention group
Group type: EXPERIMENTAL
Intervention: CXL plus standard care
Number of subjects: 60
Study 33892046 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 60
Study 32769878 — intervention group
Group type: EXPERIMENTAL
Intervention: AZL‐M 80 mg
Number of subjects: 612
Study 32769878 — intervention group
Group type: EXPERIMENTAL
Intervention: AZL‐M 40 mg
Number of subjects: 612
Study 32769878 — intervention group
Group type: COMPARATOR
Intervention: valsartan 160 mg
Number of subjects: 612
Study 36357159 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen
Number of subjects: 60
Study 36357159 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 33722866 — intervention group
Group type: EXPERIMENTAL
Intervention: Free distribution of medicines
Number of subjects: 268
Study 32718515 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based virtual animated health counselor intervention
Number of subjects: 528
Study 33253678 — intervention group
Group type: EXPERIMENTAL
Intervention: Culprit‐lesion‐only PCI
Number of subjects: 667
Study 33253678 — intervention group
Group type: COMPARATOR
Intervention: CTO presence
Number of subjects: 667
Study 32325257 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 days of filgrastim
Number of subjects: 466
Study 32325257 — intervention group
Group type: COMPARATOR
Intervention: 7/10 days of filgrastim
Number of subjects: 466
Study 35631300 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT supplementation (n = 9)
Number of subjects: 17
Study 35631300 — intervention group
Group type: COMPARATOR
Intervention: No supplementation (n = 8)
Number of subjects: 17
Study 33640577 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for Overall Survival (OS)
Number of subjects: 0
Study 33640577 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for Freedom from Locoregional Recurrence (FFLR)
Number of subjects: 0
Study 33640577 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for Freedom from Distant Metastasis (FFDM)
Number of subjects: 0
Study 34652086 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 48
Study 34652086 — intervention group
Group type: EXPERIMENTAL
Intervention: Iyengar Yoga
Number of subjects: 48
Study 34652086 — intervention group
Group type: COMPARATOR
Intervention: Control Group (General Education)
Number of subjects: 48
Study 32736216 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise training (aerobic and Pilates training, 3 sessions per week for 8 weeks)
Number of subjects: 34
Study 32736216 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise training
Number of subjects: 34
Study 32736216 — intervention group
Group type: COMPARATOR
Intervention: Control Group (relaxation exercises at home)
Number of subjects: 34
Study 34930617 — intervention group
Group type: EXPERIMENTAL
Intervention: veliparib during chemotherapy and maintenance (veliparib-throughout)
Number of subjects: 1132
Study 34930617 — intervention group
Group type: EXPERIMENTAL
Intervention: veliparib during chemotherapy followed by placebo maintenance (veliparib-combination only)
Number of subjects: 1132
Study 34930617 — intervention group
Group type: COMPARATOR
Intervention: placebo during chemotherapy and maintenance (control)
Number of subjects: 1132
Study 32096571 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin
Number of subjects: 419
Study 32096571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 419
Study 35179587 — intervention group
Group type: EXPERIMENTAL
Intervention: PROTECT intervention group
Number of subjects: 422
Study 35179587 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 422
Study 33911032 — intervention group
Group type: EXPERIMENTAL
Intervention: Greenlight intervention
Number of subjects: 865
Study 33911032 — intervention group
Group type: COMPARATOR
Intervention: Attention-control arm
Number of subjects: 865
Study 32854752 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-session psychoeducational intervention (n = 60)
Number of subjects: 120
Study 32854752 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 60)
Number of subjects: 120
Study 34775283 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 54
Study 34775283 — intervention group
Group type: COMPARATOR
Intervention: Health education (HE) control
Number of subjects: 54
Study 32678285 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal cerebellar transcranial direct current stimulation (ctDCS)
Number of subjects: 30
Study 36341232 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 59
Study 36341232 — intervention group
Group type: COMPARATOR
Intervention: Standard-care (low FODMAP diet, Otilonium Bromide 1 tablet TID, multi-strain probiotic 1 capsule BID for 1 month)
Number of subjects: 59
Study 34028790 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified CART algorithm for local disease (I)
Number of subjects: 0
Study 34028790 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified CART algorithm for ≤3 positive nodes (II)
Number of subjects: 0
Study 34028790 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified CART algorithm for ≥4 positive nodes (III)
Number of subjects: 0
Study 34028790 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified CART algorithm for presence of distant metastases (IV)
Number of subjects: 0
Study 35500316 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFAs group (EN combined with PN enriched with n-3 PUFAs from postoperative Day 1 to Day 5)
Number of subjects: 120
Study 35500316 — intervention group
Group type: COMPARATOR
Intervention: Control group (EN combined with PN without n-3 PUFAs)
Number of subjects: 120
Study 33246489 — intervention group
Group type: EXPERIMENTAL
Intervention: UCB+EPO
Number of subjects: 88
Study 33246489 — intervention group
Group type: COMPARATOR
Intervention: UCB+placebo EPO
Number of subjects: 88
Study 33246489 — intervention group
Group type: COMPARATOR
Intervention: placebo UCB+EPO
Number of subjects: 88
Study 33246489 — intervention group
Group type: COMPARATOR
Intervention: placebo UCB+placebo EPO
Number of subjects: 88
Study 36067479 — intervention group
Group type: EXPERIMENTAL
Intervention: dHACA plus Standard of Care (SOC)
Number of subjects: 60
Study 36067479 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly dHACA plus SOC
Number of subjects: 60
Study 36067479 — intervention group
Group type: EXPERIMENTAL
Intervention: Biweekly dHACA plus SOC
Number of subjects: 60
Study 36067479 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 60
Study 36067479 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 36067479 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse Events (AEs)
Number of subjects: 60
Study 34261526 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogenic FMT (screened and processed donor stool)
Number of subjects: 0
Study 34261526 — intervention group
Group type: COMPARATOR
Intervention: Autologous FMT (their own stool)
Number of subjects: 0
Study 35705354 — intervention group
Group type: EXPERIMENTAL
Intervention: High-definition transcranial infraslow pink noise stimulation (HD-tIPNS)
Number of subjects: 40
Study 35705354 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 40
Study 34034036 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 40
Study 34034036 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 40
Study 34034036 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study 33985435 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe chemotherapy-induced neutropenia (CIN)
Number of subjects: 1529
Study 33985435 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild chemotherapy-induced neutropenia (CIN)
Number of subjects: 1529
Study 33985435 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe and mild chemotherapy-induced neutropenia (CIN) in out-of-landmark group
Number of subjects: 1529
Study 32133902 — intervention group
Group type: EXPERIMENTAL
Intervention: Information and communication technology system for pain management
Number of subjects: 0
Study 32133902 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 34242412 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed approach for sample size estimation using frailty models
Number of subjects: 0
Study 34242412 — intervention group
Group type: COMPARATOR
Intervention: Existing methods for sample size estimation
Number of subjects: 0
Study 33183883 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet (LFD)
Number of subjects: 95
Study 33183883 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 95
Study 33183883 — intervention group
Group type: COMPARATOR
Intervention: Sham diet
Number of subjects: 95
Study 33183883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 35410754 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib granule (25 mg)
Number of subjects: 24
Study 35410754 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib capsule (50 mg [2 x 25 mg])
Number of subjects: 24
Study 35410754 — intervention group
Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 24
Study 35410754 — intervention group
Group type: EXPERIMENTAL
Intervention: Granule formulation
Number of subjects: 24
Study 32720695 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 944
Study 32720695 — intervention group
Group type: COMPARATOR
Intervention: QuantiFERON-gold-in-tube (QGIT)
Number of subjects: 944
Study 32720695 — intervention group
Group type: COMPARATOR
Intervention: Tuberculin skin test (TST)
Number of subjects: 944
Study 36075073 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 290
Study 32994594 — intervention group
Group type: EXPERIMENTAL
Intervention: budesonide/formoterol Turbuhaler 200/6mcg one actuation as required
Number of subjects: 890
Study 32994594 — intervention group
Group type: COMPARATOR
Intervention: budesonide Turbuhaler 200mcg one actuation twice daily and terbutaline Turbuhaler 250mcg two actuations as required
Number of subjects: 890
Study 35864051 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital plasma
Number of subjects: 501
Study 35864051 — intervention group
Group type: COMPARATOR
Intervention: Control (REF group)
Number of subjects: 501
Study 34380643 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib 420 mg once daily
Number of subjects: 31
Study 33202607 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet-based intervention (MedDiet supplemented with Extra Virgin Olive Oil/pistachios)
Number of subjects: 544
Study 33202607 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) recommended to limit fat intake
Number of subjects: 544
Study 33202607 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-world group (RW) applying IG recommendations
Number of subjects: 544
Study 33202607 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet-based intervention (MedDiet)
Number of subjects: 544
Study 33301613 — intervention group
Group type: EXPERIMENTAL
Intervention: Ravulizumab every 8 weeks
Number of subjects: 191
Study 33301613 — intervention group
Group type: COMPARATOR
Intervention: Eculizumab followed by ravulizumab
Number of subjects: 191
Study 33499376 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling focused on dietary fat quality (n = 108)
Number of subjects: 1062
Study 33499376 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 124)
Number of subjects: 1062
Study 34687308 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling with conventional physical therapy
Number of subjects: 69
Study 34687308 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling with conventional physical therapy
Number of subjects: 69
Study 34687308 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (control group)
Number of subjects: 69
Study 33774105 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-stage technique education
Number of subjects: 155
Study 33774105 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration-based teaching
Number of subjects: 155
Study 33774105 — intervention group
Group type: COMPARATOR
Intervention: Usual training (Control)
Number of subjects: 155
Study 32833050 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasitized larvae (PL) with copepods
Number of subjects: 190
Study 32833050 — intervention group
Group type: COMPARATOR
Intervention: Non-parasitized larvae (NPL)
Number of subjects: 190
Study 32833050 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasitized larvae (PL)
Number of subjects: 190
Study 34232419 — intervention group
Group type: EXPERIMENTAL
Intervention: ASSIST intervention
Number of subjects: 91
Study 34992881 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose radiation therapy (RT)
Number of subjects: 10
Study 34992881 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 10
Study 36310517 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal physiotherapy intervention (exercise therapy and patient education)
Number of subjects: 115
Study 36310517 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSS high group (HT)
Number of subjects: 115
Study 35425844 — intervention group
Group type: COMPARATOR
Intervention: Control (3 mL of subcutaneous 0.5% bupivacaine)
Number of subjects: 62
Study 35425844 — intervention group
Group type: EXPERIMENTAL
Intervention: HVIGI (10 mL of 0.5% bupivacaine and 30 mL of normal saline, ultrasound‐guided between tendon and underlying fat pad)
Number of subjects: 62
Study 35425844 — intervention group
Group type: EXPERIMENTAL
Intervention: HVIGI with steroid (0.25 mL of 100 mg/mL hydrocortisone)
Number of subjects: 62